homebusiness NewsBarclays slashes India's FY22 GDP forecast to 10% amid COVID 19 surge

Barclays slashes India's FY22 GDP forecast to 10% amid COVID-19 surge

Barclays Securities has cut India’s GDP growth forecast for FY2021-22 to 10 percent YoY from 11 percent earlier due to the fast spreading second wave of the COVID-19 pandemic. The report predicted that the economic losses could be "much higher" because of the slow pace of vaccinations. It said there are doubts over the number of cases and deaths being reported.

Profile image

By CNBC-TV18 May 3, 2021 6:32:55 PM IST (Updated)

Listen to the Article(6 Minutes)
Barclays slashes India's FY22 GDP forecast to 10% amid COVID-19 surge
Barclays Securities has cut India’s GDP growth forecast for financial year 2021-22 to 10 percent year-on-year from 11 percent earlier due to the fast spreading second wave of COVID-19 pandemic, reported Business Today.

Share Market Live

View All

Barclays researcher Rahul Bajoria and Shreya Sodhani said the economic impact of the second COVID-19 pandemic could be "much higher" in the research note titled ‘India: Tracking COVID-19 and Vaccines,’ the report added.
The researchers are of the view that if Indian states continue with COVID-19 related restrictions till August 2021, it could result in a downside of 120 basis points on annual real GDP growth, dragging FY2021-22 growth to 8.8 percent YoY.
The researchers also predicted that the economic losses could be much higher due to the slow pace of vaccination and lockdowns in various states.
The Barclays note said that there is growing uncertainty around the number of cases and fatalities because of the ongoing second COVID-19 wave in India. It also added, ‘slowing vaccinations are hurting India's recovery prospects.’
India has reported over 3.6 lakh new COVID-19 cases on May 3 and 3,417 deaths in the last 24 hours, according to the health ministry data.
India has started a mass immunisation programme with an aim to cover everyone above the age of 18 but many states have not been able to begin vaccination due to rising supply constraints and logistical challenges.
With India not going for a nationwide lockdown so far, Barclays felt that the economic costs of the current surge in novel COVID-19 cases are much lower than during last year's national lockdown, but the bill is rising, the report said.

Most Read

Share Market Live

View All
Top GainersTop Losers
CurrencyCommodities
CurrencyPriceChange%Change